Newsletter - View NlInhalteArzneimittelletter2016

ID	3662
Arzneimittelletter2016	2022-11-22
Typ	Beitrag
Element	8837
Info	[Universal 2016] [Banner] Banner Glenmark Abirateron (PS) (8837)
Position	6
In Inhalt	0
html	<!-- ------------------------------------------------------------------ --> <table> <tbody> <tr> <th class="force-col" style="font-weight:normal;text-align:left;" valign="top"> <table class="news_first_2" dir="ltr" width="660"> <tbody> <tr> <td> <p> <a target="_blank" href="https://www.glenmark.de/praeparate/abirateron-glenmark-filmtabletten/" style="text-decoration:none;color:#005CA9;"> <img class="image-topthema" src="https://www.deutschesapothekenportal.de/newsletter/2022q4/newsletter_2022-11-22_g3.jpg" width="660" vspace="10"> </a> </p> </td> </tr> </tbody> </table> </th> </tr> </tbody> </table>

Arzneimittelletter2016

2022-11-22

Element

8837

Position

6

html

<!-- ------------------------------------------------------------------ -->
        <table>
            <tbody>
                <tr>
                    <th class="force-col" style="font-weight:normal;text-align:left;" valign="top">
                        <table class="news_first_2" dir="ltr" width="660">
                            <tbody>
                                <tr>
                                    <td>
                                        <p>
                                            <a target="_blank" href="https://www.glenmark.de/praeparate/abirateron-glenmark-filmtabletten/" style="text-decoration:none;color:#005CA9;">
                                                <img class="image-topthema" src="https://www.deutschesapothekenportal.de/newsletter/2022q4/newsletter_2022-11-22_g3.jpg" width="660" vspace="10">
                                            </a>
                                        </p>
                                    </td>
                                </tr>
                            </tbody>
                        </table>
                    </th>
                </tr>
            </tbody>
        </table>

View InhalteArzneimittelletter2016 #3662